Scientists show in the animal model that the messenger CXCL12 could be suitable as a target structure for the therapy of blood clotting disorders.
Selected Program Items
So far, there are only a few medicines for heart failure patients with cardiac arrhythmias. Those that are approved often have severe side effects.…
DZHK Board Spokesperson Prof. Dr. Stefanie Dimmeler has been awarded with the Otto Warburg Medal of the Society for Biochemistry and Molecular Biology…
World's largest study reveals risks
Prof. Dr. Dagmar Krefting is the new director of the Institute of Medical Informatics at the University Medical Center Göttingen. In September 2019,…
The newly developed risk score predicts the 1-year risk of severe bleeding for patients after inpatient treatment for the symptomatic peripheral…
The current standard diagnostic test for intermediate-risk patients is is a minimally invasive catheter examination.Under the leadership of Charité –…
On February 15, 2022, the Clinic for Rhythmology was founded at the Lübeck Campus of the University Hospital Schleswig-Holstein (UKSH). In this…
Changes in the gut microbiome can ultimately lead to cardiovascular disease. Yet some of the alterations appear to normalize in chronic conditions, a…